Coon has served
as a co-founder,
executive management, and strategic partner for numerous healthcare and biotech startup companies, including roles as President of RxGen, President and CEO of BCS, Inc., President and CEO of HepatoTech, Inc., Executive Vice-President of CellzDirect (acquired by Invitrogen - Life Technologies), and the Senior Director of Business Development for RTI Inter
executive management, and strategic partner for numerous healthcare and biotech startup companies, including roles
as President of RxGen, President and CEO of BCS, Inc., President and CEO of HepatoTech, Inc.,
Executive Vice-President of CellzDirect (acquired by Invitrogen - Life Technologies), and the Senior Director of Business Development for RTI Inter
Executive Vice-President of CellzDirect (acquired by Invitrogen - Life Technologies), and the
Senior Director of Business Development for RTI International.